筛选
科学数据
统计数据
共检索到146条 ,权限内显示50条;
Data from: Total A?42/A?40 ratio in plasma predict amyloid-PET status, independent of clinical AD diagnosis
- 负责人：
- DOI：
- doi:10.5061/dryad.f300d56
- 摘要：
- ly reducing the screening rate of failure (SRF) for clinical trials targeting pre-clinical or prodromal disease. Classification of evidence: This study prov
Data from: Volunteer motivators for participating in HIV vaccine clinical trials in Nairobi, Kenya
- 负责人：
- DOI：
- doi:10.5061/dryad.77gr3
- 摘要：
- and follow-up. Understanding the factors that motivate volunteers to participate in a clinical trial can help to strategize, refine targeting and thus increase
Data from: Genetic mapping of novel loci affecting canine blood phenotypes
- 负责人：
- DOI：
- doi:10.5061/dryad.30c8p
- 摘要：
- (14 hematological tests and 25 clinical chemistry tests). After correcting for age, body weight and sex, genetic associations were identified
Data from: Head-to-head drug comparisons in multiple sclerosis: urgent action needed
- 负责人：
- DOI：
- doi:10.5061/dryad.h5g7nt7
- 摘要：
- Disease-modifying drugs are changing the natural history of multiple sclerosis (MS). However, currently available clinical trial data ar
Data from: The clinical, histological, and genotypic spectrum of SEPN1-related myopathy: a case series
- 负责人：
- DOI：
- doi:10.5061/dryad.nzs7h44nj
- 摘要：
- for clinical trial readiness in this not-so-rare disease.
Data from: Assessment of disease progression in dysferlinopathy – a one year cohort study
- 负责人：
- DOI：
- doi:10.5061/dryad.tp08m60
- 摘要：
- e required to determine clinical effectiveness for a hypothetical 1 year clinical trial based on the a-NSAA as a clinical endpoint. Conclusion: Cer
Data from: ALS drug development guidances and trial guidelines: consensus and opportunities for alignment
- 负责人：
- DOI：
- doi:10.5061/dryad.43qc486
- 摘要：
- and update the ALS clinical trial guidelines. We discuss the areas of agreement of these three documents, and the areas that provide opportunities to improve
Data from: Clinical study reports of randomised controlled trials: an exploratory review of previously confidential industry reports
- 负责人：
- DOI：
- doi:10.5061/dryad.331f7
- 摘要：
- source of detailed and exhaustive data on each trial. They should be consulted by independent parties interested in a detailed record of a clinical trial
Data from: NIHSS cut-point for predicting outcome in supra- vs infra-tentorial acute ischemic stroke
- 负责人：
- DOI：
- doi:10.5061/dryad.1kn74rt
- 摘要：
- of the randomised controlled trial, Enhanced Control of Hypertension and Thrombolysis Stroke Study (ENCHANTED). Associations between baseline characteristics of clinically-defined
Data from: Trial-results reporting and academic medical centers.
- 负责人：
- 关键词：
- clinical research transprency;ClinicalTrials.gov;academic medical centers;trial results reporting
- DOI：
- doi:10.5061/dryad.kv462
- 摘要：
- lude the results of trials of unapproved products, and a draft policy requiring the results of all National Institutes of Health (NIH)-funded trials, including
